Breast Cancer: Global Quality Care
Herausgeber: Verhoeven, Didier; Siesling, Sabine; Mansel, Robert; Kaufman, Cary
Breast Cancer: Global Quality Care
Herausgeber: Verhoeven, Didier; Siesling, Sabine; Mansel, Robert; Kaufman, Cary
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Developing or existing breast cancer centres strive to provide the highest quality care possible within their current financial and personnel resources. Written by a team of over 100 experts from 25 countries, this book provides a practical and comprehensive guide to delivering high quality breast cancer care wherever you live.
Andere Kunden interessierten sich auch für
- Pharmacogenetics of Breast Cancer112,99 €
- Katarzyna RygielThe Management of Metastatic Triple-Negative Breast Cancer84,99 €
- Robin Anne StoreyMaking The Breast Of It12,99 €
- Lisa M. Schwartz MDTHRIVE Beyond Breast Cancer Journal21,99 €
- Princess Diane von BrainisfriedBonjour, Breast Cancer - I'm Still Smiling!19,99 €
- Brittany MathiasA Simplified and Sometimes Sassy Guide to Breast Cancer56,99 €
- Petrina BurnettIt's Not (Just) About The Breast22,99 €
-
-
-
Developing or existing breast cancer centres strive to provide the highest quality care possible within their current financial and personnel resources. Written by a team of over 100 experts from 25 countries, this book provides a practical and comprehensive guide to delivering high quality breast cancer care wherever you live.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 432
- Erscheinungstermin: 19. Januar 2020
- Englisch
- Abmessung: 244mm x 170mm x 23mm
- Gewicht: 748g
- ISBN-13: 9780198839248
- ISBN-10: 0198839243
- Artikelnr.: 57468523
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Oxford University Press
- Seitenzahl: 432
- Erscheinungstermin: 19. Januar 2020
- Englisch
- Abmessung: 244mm x 170mm x 23mm
- Gewicht: 748g
- ISBN-13: 9780198839248
- ISBN-10: 0198839243
- Artikelnr.: 57468523
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Didier Verhoeven is Head of the Department of Medical Oncology at AZ Klina, and Chair of the Breast Clinic Voorkempen, in Brasschaat, Belgium, and Guest Professor at the University of Antwerp, Antwerp, Belgium. Cary S. Kaufman is Medical Director at Bellingham Regional Breast Center, Bellingham, and Associate Professor of Surgery at the University of Washington, Seattle, USA. Previously he was President of the National Accreditation Program for Breast Centers (NAPBC), and President of the National Consortium of Breast Centers (NCBC). Robert Mansel is Chair of the Quality Assurance Committee of the ECIBC, and Professor Emeritus of Surgery at the University of Cardiff School of Medicine, Cardiff, UK. He was formerly President of the European Society of Breast Cancer Specialists (EUSOMA). Sabine Siesling is Professor of Outcomes Research and Personalized Cancer Care at the University of Twente, Enschede, and Senior Researcher at the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. She was formerly President of the Netherlands Epidemiology Society, and General Secretary of the International Association of Cancer Registries (IACR).
* Part 1: Epidemiology
* 1: The global burden of malignant breast cancer in women
* 2: Cancer registries
* Part 2: Quality management of breast cancer: accreditation programs
and quality control
* 3: Opportunities and pitfalls of quality management
* 4: EUSOMA : Pioneering mastology and breast centres networking
* 5: What defines a breast center?: A NAPBC vision
* 6: A view on 'Patient-reported outcome measures'
* 7: Examples of national programs on quality management
* 8: Educational and training harmonisation in breast care
* Part 3: The guidelines
* 9: The role of guidelines in breast cancer management in different
resource settings
* Part 4: The multidisciplinary meeting
* 10: The multidisciplinary meeting: hallmark of multidisciplinary care
* Part 5: Quality control of breast cancer diagnosis and treatment
* 11: Radiology
* 12: Pathology
* 13: Surgery
* 14: Reconstructive surgery, including oncoplastic surgery
* 15: Radiotherapy
* 16: Global requirements for systemic therapy
* 17: Primary care providers (general practitioners): a shared care
approach
* 18: End of life care
* 19: Nursing clinics, nurse practitioners, and navigators
* 20: Psycho-oncological care and survivorship
* 21: Genetics
* Part 6: Health information technology (HIT)
* 22: Improving treatment value using HIT
* 23: Use of HIT for remote advice
* Part 7: Breast cancer research
* 24: The changing clinical research pathway
* 25: Global perspective
* 26: FUTURE: Challenges and Threats
* Part 8: The economics of breast cancer care
* 27: Assessing costs and value for money of breast cancer care
* 28: The economic impact of breast cancer in the Southeast Asian
region
* 29: Moving from a 'one size fits all' to a personalized strategy
* Part 9: Patients, physicians, and the media
* 30: Patients, physicians, and the media: who controls the message?
* 31: Medico-legal aspects
* Part 10: The role of governments and executives
* 32: A European perspective
* 33: Perspectives on the governance and management of breast care in
the US
* 34: Perspective from Latin-America
* 35: Perspective from India
* 36: Perspective from South Africa and Subsahara region
* 37: Optimization of breast cancer management in low and middle income
countries
* 38: Conclusion
* 1: The global burden of malignant breast cancer in women
* 2: Cancer registries
* Part 2: Quality management of breast cancer: accreditation programs
and quality control
* 3: Opportunities and pitfalls of quality management
* 4: EUSOMA : Pioneering mastology and breast centres networking
* 5: What defines a breast center?: A NAPBC vision
* 6: A view on 'Patient-reported outcome measures'
* 7: Examples of national programs on quality management
* 8: Educational and training harmonisation in breast care
* Part 3: The guidelines
* 9: The role of guidelines in breast cancer management in different
resource settings
* Part 4: The multidisciplinary meeting
* 10: The multidisciplinary meeting: hallmark of multidisciplinary care
* Part 5: Quality control of breast cancer diagnosis and treatment
* 11: Radiology
* 12: Pathology
* 13: Surgery
* 14: Reconstructive surgery, including oncoplastic surgery
* 15: Radiotherapy
* 16: Global requirements for systemic therapy
* 17: Primary care providers (general practitioners): a shared care
approach
* 18: End of life care
* 19: Nursing clinics, nurse practitioners, and navigators
* 20: Psycho-oncological care and survivorship
* 21: Genetics
* Part 6: Health information technology (HIT)
* 22: Improving treatment value using HIT
* 23: Use of HIT for remote advice
* Part 7: Breast cancer research
* 24: The changing clinical research pathway
* 25: Global perspective
* 26: FUTURE: Challenges and Threats
* Part 8: The economics of breast cancer care
* 27: Assessing costs and value for money of breast cancer care
* 28: The economic impact of breast cancer in the Southeast Asian
region
* 29: Moving from a 'one size fits all' to a personalized strategy
* Part 9: Patients, physicians, and the media
* 30: Patients, physicians, and the media: who controls the message?
* 31: Medico-legal aspects
* Part 10: The role of governments and executives
* 32: A European perspective
* 33: Perspectives on the governance and management of breast care in
the US
* 34: Perspective from Latin-America
* 35: Perspective from India
* 36: Perspective from South Africa and Subsahara region
* 37: Optimization of breast cancer management in low and middle income
countries
* 38: Conclusion
* Part 1: Epidemiology
* 1: The global burden of malignant breast cancer in women
* 2: Cancer registries
* Part 2: Quality management of breast cancer: accreditation programs
and quality control
* 3: Opportunities and pitfalls of quality management
* 4: EUSOMA : Pioneering mastology and breast centres networking
* 5: What defines a breast center?: A NAPBC vision
* 6: A view on 'Patient-reported outcome measures'
* 7: Examples of national programs on quality management
* 8: Educational and training harmonisation in breast care
* Part 3: The guidelines
* 9: The role of guidelines in breast cancer management in different
resource settings
* Part 4: The multidisciplinary meeting
* 10: The multidisciplinary meeting: hallmark of multidisciplinary care
* Part 5: Quality control of breast cancer diagnosis and treatment
* 11: Radiology
* 12: Pathology
* 13: Surgery
* 14: Reconstructive surgery, including oncoplastic surgery
* 15: Radiotherapy
* 16: Global requirements for systemic therapy
* 17: Primary care providers (general practitioners): a shared care
approach
* 18: End of life care
* 19: Nursing clinics, nurse practitioners, and navigators
* 20: Psycho-oncological care and survivorship
* 21: Genetics
* Part 6: Health information technology (HIT)
* 22: Improving treatment value using HIT
* 23: Use of HIT for remote advice
* Part 7: Breast cancer research
* 24: The changing clinical research pathway
* 25: Global perspective
* 26: FUTURE: Challenges and Threats
* Part 8: The economics of breast cancer care
* 27: Assessing costs and value for money of breast cancer care
* 28: The economic impact of breast cancer in the Southeast Asian
region
* 29: Moving from a 'one size fits all' to a personalized strategy
* Part 9: Patients, physicians, and the media
* 30: Patients, physicians, and the media: who controls the message?
* 31: Medico-legal aspects
* Part 10: The role of governments and executives
* 32: A European perspective
* 33: Perspectives on the governance and management of breast care in
the US
* 34: Perspective from Latin-America
* 35: Perspective from India
* 36: Perspective from South Africa and Subsahara region
* 37: Optimization of breast cancer management in low and middle income
countries
* 38: Conclusion
* 1: The global burden of malignant breast cancer in women
* 2: Cancer registries
* Part 2: Quality management of breast cancer: accreditation programs
and quality control
* 3: Opportunities and pitfalls of quality management
* 4: EUSOMA : Pioneering mastology and breast centres networking
* 5: What defines a breast center?: A NAPBC vision
* 6: A view on 'Patient-reported outcome measures'
* 7: Examples of national programs on quality management
* 8: Educational and training harmonisation in breast care
* Part 3: The guidelines
* 9: The role of guidelines in breast cancer management in different
resource settings
* Part 4: The multidisciplinary meeting
* 10: The multidisciplinary meeting: hallmark of multidisciplinary care
* Part 5: Quality control of breast cancer diagnosis and treatment
* 11: Radiology
* 12: Pathology
* 13: Surgery
* 14: Reconstructive surgery, including oncoplastic surgery
* 15: Radiotherapy
* 16: Global requirements for systemic therapy
* 17: Primary care providers (general practitioners): a shared care
approach
* 18: End of life care
* 19: Nursing clinics, nurse practitioners, and navigators
* 20: Psycho-oncological care and survivorship
* 21: Genetics
* Part 6: Health information technology (HIT)
* 22: Improving treatment value using HIT
* 23: Use of HIT for remote advice
* Part 7: Breast cancer research
* 24: The changing clinical research pathway
* 25: Global perspective
* 26: FUTURE: Challenges and Threats
* Part 8: The economics of breast cancer care
* 27: Assessing costs and value for money of breast cancer care
* 28: The economic impact of breast cancer in the Southeast Asian
region
* 29: Moving from a 'one size fits all' to a personalized strategy
* Part 9: Patients, physicians, and the media
* 30: Patients, physicians, and the media: who controls the message?
* 31: Medico-legal aspects
* Part 10: The role of governments and executives
* 32: A European perspective
* 33: Perspectives on the governance and management of breast care in
the US
* 34: Perspective from Latin-America
* 35: Perspective from India
* 36: Perspective from South Africa and Subsahara region
* 37: Optimization of breast cancer management in low and middle income
countries
* 38: Conclusion